977-981
Expression of p-PPARγ in the aging thoracic aorta of spontaneously hypertensive rat and inhibitory effect of rosiglitazone
Authors: Hai-Feng Yuan, Xiao-Lin Niu, Deng-Feng Gao, Guang-Hua Hao, An-Qi Song, Jin Wei
Number of views: 278
Objective: To investigate the expression of phosphorylated peroxisome proliferators-activated
receptor γ (p-PPARγ) in the aging thoracic aorta of spontaneously hypertensive rat (SHR) and
the inhibitory effect of rosiglitazone on the phosphorylation of PPARγ.
Methods: 16, 32 and 64 week-old Wistar-Kyoto rats (WKY) and SHR were randomly and
respectively divided into WKY, SHR and SHR+rosiglitazone group (9 in each group). The rats
in SHR+rosiglitazone group were treated with rosiglitazone (5 mg/kg, intragastrically) for 56
d, whereas normal saline was applied in WKY and SHR groups. Systolic blood pressure (SBP)
of rats was measured by tail cuff method. Histopathological damage of thoracic aorta was
analyzed using Hematoxylin-Eosin (HE) staining. Immunohistochemical staining and western
blot were performed to test the level of p-PPARγ protein in the thoracic aorta arising from each
group.
Results: The SBP in 16, 32 and 64 week-old SHR were significantly higher as compared with
those in matched WKY rats (P<0.05, respectively). HE staining showed increased content of
smooth muscle cell, wrinkled lining endothelium and increased thickness of internal elastic
lamina in the thoracic aorta of SHR. Immunohistochemical staining and western blot indicated
that the levels of p-PPARγ in the thoracic aorta arising from SHR were obviously higher than
those in the thoracic aorta arising from WKY rats (P<0.05, respectively). Importantly, the high
SBP, histopathological abnormalities of the thoracic aorta and elevated p-PPARγ expression
were prominently abrogated by rosiglitazone treatment in SHR (P<0.05, respectively).
Furthermore, the SBP, histopathological abnormalities of the thoracic aorta and p-PPARγ
expression were positively correlated with age in SHR (P<0.05, respectively).
Conclusions: The PPARγ phosphorylation was observed in the thoracic aorta of SHR and
its expression was increased by the increase of age. Furthermore, rosiglitazone inhibited the
PPARγ phosphorylation and suppressed vascular aging in SHR.